share_log

ABVC Biopharma Collaboration Between ABVC And Oncox Biopharma, ABVC Expecting Aggregate Income Of $13.75M And Royalties Of Up To $12.50M; Grants Oncox Exclusive Rights For One Of Abvc's Four Products In Its Oncology Pipeline To Develop, Manufacture,...

Benzinga ·  May 9 21:41

ABVC Biopharma Collaboration Between ABVC And Oncox Biopharma, ABVC Expecting Aggregate Income Of $13.75M And Royalties Of Up To $12.50M; Grants Oncox Exclusive Rights For One Of Abvc's Four Products In Its Oncology Pipeline To Develop, Manufacture, Commercialize Blex 404

https://www.sec.gov/ix?doc=/Archives/edgar/data/1173313/000121390024041053/ea0205569-8k_abvcbio.htm

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment